Indeed, our study showed that the overexpression of IL-15 in tumor cells facilitated antitumor immune responses, as evidenced by an increase in the number and enhancement of effector functions of CD8+ T cells in tumors compared to those in wild-type LLC tumors. The gene discussed is CD8A; the disease is neoplasm.